A study has found that a combination of senolytic drugs can delay early intervertebral disc degeneration in mice. The treatment, which includes dasatinib and quercetin, has shown potential in slowing spinal disc degeneration. Research suggests this therapy could be a preventive strategy for spine degeneration and related pain.